Mittelbiberach, Germany

Kai Gerlach

USPTO Granted Patents = 38 

 

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Ulm, DE (2006 - 2008)
  • Biberach, DE (2008 - 2015)
  • Ingelheim am Rhein, DE (2019 - 2023)
  • Mittelbiberach, DE (2009 - 2024)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents

Title: Innovations of Kai Gerlach in Pharmaceutical Patents

Introduction

Kai Gerlach, located in Mittelbiberach, Germany, has made significant contributions to the field of pharmaceuticals, securing an impressive total of 36 patents. His inventions primarily focus on novel compounds that target various diseases, showcasing his expertise and innovative prowess in medicinal chemistry.

Latest Patents

Among his recent inventions is a patent for CCR2 receptor antagonists and their applications. This groundbreaking invention relates to novel antagonists for CCR2 (CC chemokine receptor 2), which are designed to be utilized in the development of medications aimed at treating pulmonary diseases, including asthma and COPD. Another notable patent involves 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives. This invention describes these compounds as agonists of GPR52, which are valuable for treating central nervous system disorders and a variety of other diseases. Additionally, the patent outlines processes for preparing pharmaceutical compositions that incorporate these innovative derivatives.

Career Highlights

Kai Gerlach has established a prominent career through his work at leading pharmaceutical companies. He has been part of Boehringer Ingelheim International GmbH, where he contributed to various therapeutic developments, and Centrexion Therapeutics Corporation, focusing on bringing innovative medicinal solutions to market. His accumulated experience has greatly enriched his expertise in the field.

Collaborations

Throughout his career, Kai has collaborated with notable professionals such as Henning Priepke and Wolfgang Wienen. These collaborations have facilitated the exchange of ideas and advancements in drug formulation and innovation.

Conclusion

In summary, Kai Gerlach stands out as a prolific inventor whose work has led to several patents in the pharmaceutical industry. His innovative contributions, particularly in the development of new treatments for respiratory and central nervous system diseases, exemplify his commitment to advancing medical science and improving patient outcomes. His ongoing endeavors are eagerly anticipated within the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…